Section 3: Production and Compounding

3PC-032

DETERMINATION OF SENSITIVITY THRESHOLD FOR STERILITY ASSAY OF THE BINARY PARENTERAL NUTRITION BAGS BY DIRECT SEEDING

3PC-029

CALCULATION OF ANNUAL ECONOMIC IMPACT OF MANUFACTURING AVASTIN® SYRINGES IN THE AGERELATED MACULAR DEGENERATION TREATMENT IN OUR HOSPITAL

3PC-018

THE ADVANTAGE OF AUTOMATION IN THE PREPARATION OF CHEMOTHERAPY DRUGS FOR THE INTERCEPTION OF ERRORS

3PC-014

STABILITY STUDY OF GENTAMICIN LOCK THERAPY WITH HEPARIN OR CITRATE AS ANTICOAGULANT

3PC-011

HPLC METHOD DEVELOPMENT AND VALIDATION TO DETERMINATE RESORCINOL FOR QUALITY CONTROL IN PHARMACEUTICAL FORMULATIONS

3PC-024

APPLICATION OF A MATRIX RISK TO AN APPROPRIATE COMPOUNDING PROCESS OF AFLIBERCEPT AND RANIBIZUMAB INTRAVITREAL INJECTIONS

3PC-004

AUTOMATION OF PARENTERAL NUTRITION ELABORATION IN A HOSPITAL PHARMACY SERVICE

3PC-005

A NEW PACKAGING OF HYPERTONIC SOLUTION TO OVERCOME AN UNAVAILABLE FORMULATION IN FRANCE

3PC-002

STABILITY OF MIXTURES OF ONDANSETRON AND HALOPERIDOL STORED IN INFUSORS AT DIFFERENT TEMPERATURES

Pages